Skip to main content

Marta Rebull Santamaria

Institutions of which they are part

Research technician
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Marta Rebull Santamaria

Institutions of which they are part

Research technician
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Projects

Targeting the most aggressive type of endometrial carcinoma

IP: Antonio Gil Moreno
Collaborators: Carina Masferrer Ferragutcasas, Marta Rebull Santamaria, Irene De la Calle Fuentes, Beatriz Villafranca Magdalena, Melek Denizli
Funding agency: Asociación Española Contra el Cáncer
Funding: 199250
Reference: GCTRA18014MATI
Duration: 18/02/2019 - 31/10/2024

Alteraciones moleculares relacionadas con la progresión tumoral en el cáncer de endometrio Numero projecte extern: GCB 110333 REVE

IP: Jaume Reventós Puigjaner
Collaborators: Eva Colas Ortega, Marta Rebull Santamaria
Funding agency: Asociación Española Contra el Cáncer
Funding: 1200000
Reference: AECC- GCB 110333 REVE
Duration: 01/08/2011 - 28/07/2016

Grup de Recerca en Neurologia Infantil HUVH

IP: Alfons Macaya Ruíz
Collaborators: Susana Boronat Guerero, Francina Munell Casadesus, Miquel Raspall Chaure, Mireia del Toro Riera, Marta Rebull Santamaria, Mario Marotta Baleriola, Daniel Carranza Rojo
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 41600
Reference: 2009 SGR 78
Duration: 01/01/2010 - 30/04/2014

Oncologia Translacional

IP: Jaume Reventós Puigjaner
Collaborators: Soledad Gallego Melcón, Manuel López Cano, José Placer Santos, Josep Sánchez de Toledo Codina, Joan Morote Robles, Ma Teresa Quiles Pérez, Maria Asuncion Perez Benavente, Eva Colas Ortega, Miguel Segura Ginard, Berta Diaz Feijoo, Manuel Armengol Carrasco, Josep Castellví Vives, Silvia Cabrera Diaz, Antonio Gil Moreno, Marta Rebull Santamaria, Marina Rigau Resina, Maria Antonia Arbos Via, Jacques Planas Morin, Josep Roma Castanyer
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 57200
Reference: 2009 SGR 487
Duration: 01/01/2010 - 30/04/2014

Related news

From 6th to 7th March, more than 60 European researchers have shared the advances in translational research in endometrial cancer

On January 24, a session was held to explain what these three-dimensional models are and what advantages they have, as well as to review some of their applications in research.

A team from Vall d'Hebron Research Institute (VHIR) and the Autonomous University of Barcelona (UAB) highlights the ERK5 protein as a key factor in the resistance to cancer drugs.

Related professionals

Francisco Barranco Martinez

Francisco Barranco Martinez

Predoctoral researcher
Maternal and Fetal Medicine
Read more
Cristina Díaz Amaral

Cristina Díaz Amaral

Predoctoral researcher
Reconstructive Surgery of the Locomotor System
Read more
Silvia Serrano Robredo

Silvia Serrano Robredo

Administrative Assistant
General Services and Infrastructure
Manager
Read more
Raquel Gil Muro

Raquel Gil Muro

Research technician
Transfusional Medicine
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.